Erythropoietin Drugs Market Research Report by Drug Class (Biologics and Biosimilars), by Product (Darbepoetin-alfa, Epoetin-alfa, and Epoetin-beta), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Erythropoietin Drugs Market is expected to grow from USD 6,598.13 Million in 2020 to USD 9,348.94 Million by the end of 2025.
2. The Global Erythropoietin Drugs Market is expected to grow from EUR 5,785.36 Million in 2020 to EUR 8,197.32 Million by the end of 2025.
3. The Global Erythropoietin Drugs Market is expected to grow from GBP 5,143.20 Million in 2020 to GBP 7,287.44 Million by the end of 2025.
4. The Global Erythropoietin Drugs Market is expected to grow from JPY 704,187.79 Million in 2020 to JPY 997,768.88 Million by the end of 2025.
5. The Global Erythropoietin Drugs Market is expected to grow from AUD 9,581.36 Million in 2020 to AUD 13,575.90 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Erythropoietin Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Drug Class, the Erythropoietin Drugs Market studied across Biologics and Biosimilars.
Based on Product, the Erythropoietin Drugs Market studied across Darbepoetin-alfa, Epoetin-alfa, and Epoetin-beta.
Based on Application, the Erythropoietin Drugs Market studied across Cancer, Hematology, Neurology, and Renal Diseases.
Based on Geography, the Erythropoietin Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Erythropoietin Drugs Market including Amgen Inc., Biocon Limited, Celltrion, Inc., Hospira Inc., Intas Pharmaceuticals, Johnson & Johnson, LG Life Sciences Ltd., Ranbaxy Laboratories Ltd., Roche Holding AG, and Teva Pharmaceutical Industries Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Erythropoietin Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Erythropoietin Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Erythropoietin Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Erythropoietin Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Erythropoietin Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Erythropoietin Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Erythropoietin Drugs Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Erythropoietin Drugs Market is expected to grow from USD 6,598.13 Million in 2020 to USD 9,348.94 Million by the end of 2025.
2. The Global Erythropoietin Drugs Market is expected to grow from EUR 5,785.36 Million in 2020 to EUR 8,197.32 Million by the end of 2025.
3. The Global Erythropoietin Drugs Market is expected to grow from GBP 5,143.20 Million in 2020 to GBP 7,287.44 Million by the end of 2025.
4. The Global Erythropoietin Drugs Market is expected to grow from JPY 704,187.79 Million in 2020 to JPY 997,768.88 Million by the end of 2025.
5. The Global Erythropoietin Drugs Market is expected to grow from AUD 9,581.36 Million in 2020 to AUD 13,575.90 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Erythropoietin Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Drug Class, the Erythropoietin Drugs Market studied across Biologics and Biosimilars.
Based on Product, the Erythropoietin Drugs Market studied across Darbepoetin-alfa, Epoetin-alfa, and Epoetin-beta.
Based on Application, the Erythropoietin Drugs Market studied across Cancer, Hematology, Neurology, and Renal Diseases.
Based on Geography, the Erythropoietin Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Erythropoietin Drugs Market including Amgen Inc., Biocon Limited, Celltrion, Inc., Hospira Inc., Intas Pharmaceuticals, Johnson & Johnson, LG Life Sciences Ltd., Ranbaxy Laboratories Ltd., Roche Holding AG, and Teva Pharmaceutical Industries Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Erythropoietin Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Erythropoietin Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Erythropoietin Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Erythropoietin Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Erythropoietin Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Erythropoietin Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Erythropoietin Drugs Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Product Outlook
3.5. Application Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY DRUG CLASS
6.1. Introduction
6.2. Biologics
6.3. Biosimilars
7. GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY PRODUCT
7.1. Introduction
7.2. Darbepoetin-alfa
7.3. Epoetin-alfa
7.4. Epoetin-beta
8. GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY APPLICATION
8.1. Introduction
8.2. Cancer
8.3. Hematology
8.4. Neurology
8.5. Renal Diseases
9. AMERICAS ERYTHROPOIETIN DRUGS MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Amgen Inc.
13.2. Biocon Limited
13.3. Celltrion, Inc.
13.4. Hospira Inc.
13.5. Intas Pharmaceuticals
13.6. Johnson & Johnson
13.7. LG Life Sciences Ltd.
13.8. Ranbaxy Laboratories Ltd.
13.9. Roche Holding AG
13.10. Teva Pharmaceutical Industries Ltd.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Product Outlook
3.5. Application Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY DRUG CLASS
6.1. Introduction
6.2. Biologics
6.3. Biosimilars
7. GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY PRODUCT
7.1. Introduction
7.2. Darbepoetin-alfa
7.3. Epoetin-alfa
7.4. Epoetin-beta
8. GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY APPLICATION
8.1. Introduction
8.2. Cancer
8.3. Hematology
8.4. Neurology
8.5. Renal Diseases
9. AMERICAS ERYTHROPOIETIN DRUGS MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Amgen Inc.
13.2. Biocon Limited
13.3. Celltrion, Inc.
13.4. Hospira Inc.
13.5. Intas Pharmaceuticals
13.6. Johnson & Johnson
13.7. LG Life Sciences Ltd.
13.8. Ranbaxy Laboratories Ltd.
13.9. Roche Holding AG
13.10. Teva Pharmaceutical Industries Ltd.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOLOGICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOSIMILARS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DARBEPOETIN-ALFA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-ALFA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-BETA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY RENAL DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. ARGENTINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. ARGENTINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. BRAZIL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. BRAZIL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. BRAZIL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. CANADA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CANADA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. CANADA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. MEXICO ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. MEXICO ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. MEXICO ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. AUSTRALIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. AUSTRALIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. AUSTRALIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. CHINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. CHINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. CHINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. INDIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. INDIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. INDIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDONESIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDONESIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDONESIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. JAPAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. JAPAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. JAPAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. MALAYSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MALAYSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MALAYSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. PHILIPPINES ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. PHILIPPINES ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. PHILIPPINES ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SOUTH KOREA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SOUTH KOREA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH KOREA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. THAILAND ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. THAILAND ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. THAILAND ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. FRANCE ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. FRANCE ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. FRANCE ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. GERMANY ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. GERMANY ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. GERMANY ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. ITALY ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. ITALY ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. ITALY ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. NETHERLANDS ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. NETHERLANDS ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. NETHERLANDS ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. QATAR ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. QATAR ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. QATAR ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. RUSSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. RUSSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. RUSSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. SAUDI ARABIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. SAUDI ARABIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SAUDI ARABIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SOUTH AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SPAIN ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SPAIN ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SPAIN ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. UNITED ARAB EMIRATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. UNITED ARAB EMIRATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. UNITED ARAB EMIRATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED KINGDOM ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED KINGDOM ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED KINGDOM ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. GLOBAL ERYTHROPOIETIN DRUGS MARKET: SCORES
TABLE 104. GLOBAL ERYTHROPOIETIN DRUGS MARKET: BUSINESS STRATEGY
TABLE 105. GLOBAL ERYTHROPOIETIN DRUGS MARKET: PRODUCT SATISFACTION
TABLE 106. GLOBAL ERYTHROPOIETIN DRUGS MARKET: RANKING
TABLE 107. GLOBAL ERYTHROPOIETIN DRUGS MARKET: MERGER & ACQUISITION
TABLE 108. GLOBAL ERYTHROPOIETIN DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 109. GLOBAL ERYTHROPOIETIN DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 110. GLOBAL ERYTHROPOIETIN DRUGS MARKET: INVESTMENT & FUNDING
TABLE 111. GLOBAL ERYTHROPOIETIN DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 112. GLOBAL ERYTHROPOIETIN DRUGS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOLOGICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOSIMILARS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DARBEPOETIN-ALFA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-ALFA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-BETA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY RENAL DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. ARGENTINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. ARGENTINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. BRAZIL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. BRAZIL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. BRAZIL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. CANADA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CANADA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. CANADA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. MEXICO ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. MEXICO ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. MEXICO ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. AUSTRALIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. AUSTRALIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. AUSTRALIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. CHINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. CHINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. CHINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. INDIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. INDIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. INDIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDONESIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDONESIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDONESIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. JAPAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. JAPAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. JAPAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. MALAYSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MALAYSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MALAYSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. PHILIPPINES ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. PHILIPPINES ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. PHILIPPINES ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SOUTH KOREA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SOUTH KOREA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH KOREA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. THAILAND ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. THAILAND ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. THAILAND ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. FRANCE ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. FRANCE ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. FRANCE ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. GERMANY ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. GERMANY ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. GERMANY ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. ITALY ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. ITALY ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. ITALY ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. NETHERLANDS ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. NETHERLANDS ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. NETHERLANDS ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. QATAR ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. QATAR ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. QATAR ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. RUSSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. RUSSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. RUSSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. SAUDI ARABIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. SAUDI ARABIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SAUDI ARABIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SOUTH AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SPAIN ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SPAIN ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SPAIN ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. UNITED ARAB EMIRATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. UNITED ARAB EMIRATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. UNITED ARAB EMIRATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED KINGDOM ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED KINGDOM ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED KINGDOM ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. GLOBAL ERYTHROPOIETIN DRUGS MARKET: SCORES
TABLE 104. GLOBAL ERYTHROPOIETIN DRUGS MARKET: BUSINESS STRATEGY
TABLE 105. GLOBAL ERYTHROPOIETIN DRUGS MARKET: PRODUCT SATISFACTION
TABLE 106. GLOBAL ERYTHROPOIETIN DRUGS MARKET: RANKING
TABLE 107. GLOBAL ERYTHROPOIETIN DRUGS MARKET: MERGER & ACQUISITION
TABLE 108. GLOBAL ERYTHROPOIETIN DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 109. GLOBAL ERYTHROPOIETIN DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 110. GLOBAL ERYTHROPOIETIN DRUGS MARKET: INVESTMENT & FUNDING
TABLE 111. GLOBAL ERYTHROPOIETIN DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 112. GLOBAL ERYTHROPOIETIN DRUGS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL ERYTHROPOIETIN DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ERYTHROPOIETIN DRUGS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 6. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL ERYTHROPOIETIN DRUGS MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL ERYTHROPOIETIN DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 15. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 17. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOLOGICS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOSIMILARS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 20. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2025
FIGURE 22. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DARBEPOETIN-ALFA, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-ALFA, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-BETA, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 26. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2025
FIGURE 28. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY CANCER, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY HEMATOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY NEUROLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY RENAL DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 32. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 33. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 35. ARGENTINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. BRAZIL ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. CANADA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. MEXICO ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. AUSTRALIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. CHINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. INDIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. INDONESIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. JAPAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. MALAYSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. PHILIPPINES ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SOUTH KOREA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. THAILAND ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 55. FRANCE ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. GERMANY ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. ITALY ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. NETHERLANDS ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. QATAR ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. RUSSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SAUDI ARABIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SOUTH AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. SPAIN ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. UNITED ARAB EMIRATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. UNITED KINGDOM ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. GLOBAL ERYTHROPOIETIN DRUGS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 67. GLOBAL ERYTHROPOIETIN DRUGS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 68. GLOBAL ERYTHROPOIETIN DRUGS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY TYPE
FIGURE 1. GLOBAL ERYTHROPOIETIN DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ERYTHROPOIETIN DRUGS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 6. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL ERYTHROPOIETIN DRUGS MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL ERYTHROPOIETIN DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 15. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 17. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOLOGICS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOSIMILARS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 20. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2025
FIGURE 22. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DARBEPOETIN-ALFA, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-ALFA, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-BETA, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 26. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2025
FIGURE 28. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY CANCER, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY HEMATOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY NEUROLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY RENAL DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 32. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 33. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 35. ARGENTINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. BRAZIL ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. CANADA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. MEXICO ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. AUSTRALIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. CHINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. INDIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. INDONESIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. JAPAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. MALAYSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. PHILIPPINES ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SOUTH KOREA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. THAILAND ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 55. FRANCE ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. GERMANY ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. ITALY ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. NETHERLANDS ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. QATAR ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. RUSSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SAUDI ARABIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SOUTH AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. SPAIN ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. UNITED ARAB EMIRATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. UNITED KINGDOM ERYTHROPOIETIN DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. GLOBAL ERYTHROPOIETIN DRUGS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 67. GLOBAL ERYTHROPOIETIN DRUGS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 68. GLOBAL ERYTHROPOIETIN DRUGS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY TYPE
